NLY01

· Neuraly, Inc.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for NLY01, covering 2021-03-02 to 2024-09-19. Get the full timeline:

Most recent: Clinical Trial Update: A Clinical Study of NLY01 in Patient's With Early Parkinson's Disease [Phase 2]